Endocrinologia Diabetes Y Nutricion最新文献

筛选
英文 中文
Phase angle: Differences between disease-related malnutrition, obesity and healthy people. 相角:与疾病相关的营养不良、肥胖和健康人群之间的差异。
IF 1.8 4区 医学
Endocrinologia Diabetes Y Nutricion Pub Date : 2024-11-19 DOI: 10.1016/j.endien.2024.07.003
Mario A Saavedra Vásquez, Javier Castañón Alonso, Begoña Pintor de la Maza, Elena González Arnáiz, Diana García Sastre, Diana G Ariadel Cobo, Ana M Urioste Fondo, María Antequera González, María Del Carmen Dameto Pons, María D Ballesteros Pomar
{"title":"Phase angle: Differences between disease-related malnutrition, obesity and healthy people.","authors":"Mario A Saavedra Vásquez, Javier Castañón Alonso, Begoña Pintor de la Maza, Elena González Arnáiz, Diana García Sastre, Diana G Ariadel Cobo, Ana M Urioste Fondo, María Antequera González, María Del Carmen Dameto Pons, María D Ballesteros Pomar","doi":"10.1016/j.endien.2024.07.003","DOIUrl":"https://doi.org/10.1016/j.endien.2024.07.003","url":null,"abstract":"<p><strong>Introduction: </strong>Bioelectrical Impedance Analysis (BIA) is a tool used in clinical nutrition and pure electrical data such as phase angle (PA) has shown prognostic value. It relates resistance and reactance indicating cellular health.</p><p><strong>Objective: </strong>To determine differences in PA between patients with obesity and disease-related malnutrition (DRM) compared to the healthy population, and to establish associations between PA and other body composition (BC) parameters.</p><p><strong>Materials and methods: </strong>Retrospective observational study with 1079 patients from the Obesity and Nutrition Department of the Complejo Asistencial Universitario de León between April/2014 and August/2022 as well as 86 healthy controls. Demographic and anthropometric variables were collected and BC was performed with BIA Tanita MC780®. Diagnosis of malnutrition according to GLIM criteria and obesity with body mass index (BMI).</p><p><strong>Results: </strong>PA50KHz in obesity group is 5.98º, DRM 4.79º and control group 6.08º. Statistically significant differences in PA between DRM and control groups, as well as DRM and obesity (p < 0.001). Weak positive correlation in total population (r = 0.452, p < 0.001) as well as control group (r = 0.463, p < 0.001) between BMI and PA. Weak negative correlation in the total population (r = -0.408, p < 0.001), DRM (r = -0.268, p < 0.001) and obesity (r = -0.342, p < 0.001) between age and PA.</p><p><strong>Conclusions: </strong>In this study, significantly lower PA was observed in the DRM group than in the control and obesity groups. No statistically significant differences between PA in the obesity and control groups and no correlation between BMI and PA in the obesity group. More studies are needed to standardize cut-off points in different contexts and populations.</p>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142682848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Are we underdiagnosing cognitive impairment in patients with type 2 diabetes mellitus? 我们是否对 2 型糖尿病患者的认知障碍诊断不足?
IF 1.8 4区 医学
Endocrinologia Diabetes Y Nutricion Pub Date : 2024-11-19 DOI: 10.1016/j.endien.2024.11.009
Antelm Pujol, Pilar Sanchis, María I Tamayo, Lluís Masmiquel
{"title":"Are we underdiagnosing cognitive impairment in patients with type 2 diabetes mellitus?","authors":"Antelm Pujol, Pilar Sanchis, María I Tamayo, Lluís Masmiquel","doi":"10.1016/j.endien.2024.11.009","DOIUrl":"https://doi.org/10.1016/j.endien.2024.11.009","url":null,"abstract":"","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142682840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Automated insulin delivery systems in the treatment of diabetes: Benefits, challenges, and practical considerations in pediatric patients. 治疗糖尿病的自动胰岛素输送系统:儿科患者的益处、挑战和实际考虑因素。
IF 1.8 4区 医学
Endocrinologia Diabetes Y Nutricion Pub Date : 2024-11-19 DOI: 10.1016/j.endien.2024.11.010
Patricia Enes Romero, María Güemes, Blanca Guijo, Gabriel Á Martos-Moreno, Jesús Pozo Román, Jesús Argente
{"title":"Automated insulin delivery systems in the treatment of diabetes: Benefits, challenges, and practical considerations in pediatric patients.","authors":"Patricia Enes Romero, María Güemes, Blanca Guijo, Gabriel Á Martos-Moreno, Jesús Pozo Román, Jesús Argente","doi":"10.1016/j.endien.2024.11.010","DOIUrl":"https://doi.org/10.1016/j.endien.2024.11.010","url":null,"abstract":"<p><p>At present, the majority of patients with type 1 diabetes mellitus do not achieve the recommended glycemic control goals to reduce the risk of acute and chronic complications. Hybrid closed-loop systems or automated insulin infusion systems emerged as an opportunity to improve metabolic control, quality of life and reduce the psychosocial impact of type 1 diabetes. This article analyzes the evidence regarding their effectiveness and safety, the challenges they pose and best practices to optimize results when implemented in clinical practice.</p>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142682847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early thyroid carcinoma in PTEN syndrome. Importance of immediate ultrasound screening. PTEN综合征的早期甲状腺癌。立即进行超声波筛查的重要性。
IF 1.8 4区 医学
Endocrinologia Diabetes Y Nutricion Pub Date : 2024-11-15 DOI: 10.1016/j.endien.2024.11.006
Emilio García García, Mercedes L Llempén López, María Molina Mata, Rosa Cabello Laureano, Suset Dueñas Disotuar
{"title":"Early thyroid carcinoma in PTEN syndrome. Importance of immediate ultrasound screening.","authors":"Emilio García García, Mercedes L Llempén López, María Molina Mata, Rosa Cabello Laureano, Suset Dueñas Disotuar","doi":"10.1016/j.endien.2024.11.006","DOIUrl":"https://doi.org/10.1016/j.endien.2024.11.006","url":null,"abstract":"","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142645015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minimally invasive techniques for the management of benign thyroid nodules: Efficacy and impact on quality of life of percutaneous ethanol injection. Results from a high-resolution thyroid nodule unit. 治疗甲状腺良性结节的微创技术:经皮乙醇注射的疗效及其对生活质量的影响。高分辨率甲状腺结节检查结果。
IF 1.8 4区 医学
Endocrinologia Diabetes Y Nutricion Pub Date : 2024-11-15 DOI: 10.1016/j.endien.2024.11.003
Javier Bodoque Cubas, José Fernández Sáez, Sergio Martínez Hervás, José Vicente Gil Boix, Juan José Salazar González, Raquel María Pallarés Gassulla, Sara Martínez Pérez, Marcel la Miret Llauradó, Iñaki Argüelles Jiménez, Santiago Tofé Povedano
{"title":"Minimally invasive techniques for the management of benign thyroid nodules: Efficacy and impact on quality of life of percutaneous ethanol injection. Results from a high-resolution thyroid nodule unit.","authors":"Javier Bodoque Cubas, José Fernández Sáez, Sergio Martínez Hervás, José Vicente Gil Boix, Juan José Salazar González, Raquel María Pallarés Gassulla, Sara Martínez Pérez, Marcel la Miret Llauradó, Iñaki Argüelles Jiménez, Santiago Tofé Povedano","doi":"10.1016/j.endien.2024.11.003","DOIUrl":"https://doi.org/10.1016/j.endien.2024.11.003","url":null,"abstract":"<p><strong>Background and objective: </strong>The high incidence of thyroid nodular disease has raised concerns on the therapeutic management of benign thyroid nodules. The development of minimally invasive techniques is an alternative to surgery and has a low rate of complications. Our objective was to evaluate the safety and efficacy profile of percutaneous ethanol injections (PEI) with ethanol aspiration of symptomatic cystic and predominantly cystic thyroid nodules (cystic component > 50%) treated in the thyroid nodule high-resolution unit (TNHRU) of Hospital de Tortosa Verge de la Cinta Hospital, Tarragona, Spain.</p><p><strong>Patients and methods: </strong>The present work is a prospective, observational and descriptive study of 32 patients (87.5% women, mean age of 43; SD, 12) evaluated at the TNHRU from August 2022 through December 2023. Demographic data such as age, sex, previous thyroid function, diagnostic method, initial nodular volume, nodular composition and nodular location were analyzed. Using ultrasounds, measurements of diameters and thyroid nodule volume were taken. We aspirated a total of 50% of the cystic content and injected between 2 mL and 5 mL of 99% ethanol (depending on cystic volume). After letting the ethanol act inside the nodule for 5 to 10 minutes, all the cystic content and the injected ethanol were aspirated. We performed an ultrasound follow-up at 1, 3 and 6 months, calculating the total volume and the volume reduction rate (VRR). The impact on health-related quality of life (HRQoL) was assessed using the ThyPRO-39es questionnaire, which was administered before and after the PEI treatment at the 6-month follow-up.</p><p><strong>Results: </strong>The median volume reduction at the end of the 6-month follow-up was 0.23 mL (0.00-0.67), and the VRR, 98.57% (94.80-100.00). The difference between the initial volume and the mean volume at the 1-, 3-, and 6-month follow-ups was statistically significant, as was the VRR between the 1-month and the 3- and 6-month follow-ups. Six patients (18.80%) required 2 PEIs and only 2 patients (6.3%) required 3 PEIs. The overall quality of life, which was scored from 0 (good) to 4 (poor), significantly improved from 1.28; SD, 0.81 up to 0.19; SD, 0.40 (p < 0.001).</p><p><strong>Conclusions: </strong>PEI is an effective alternative to treat cystic thyroid nodules resulting in an improved patients' HRQoL. It can be performed outpatiently with a low rate of complications, thus making it suitable for inclusion in the service portfolio of a HRTNU.</p>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142645017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Massive switch to an automated insulin delivery system in adults with type 1 diabetes previously treated with sensor-augmented pump due to high risk for hypoglycemia. 由于低血糖风险高,之前使用传感器增强泵治疗的 1 型糖尿病成人患者大规模改用胰岛素自动给药系统。
IF 1.8 4区 医学
Endocrinologia Diabetes Y Nutricion Pub Date : 2024-11-12 DOI: 10.1016/j.endien.2024.11.004
Alex Mesa, Daria Roca, Montse Granados, Irene Pueyo, Carla Cabré, Antonio J Amor, Clara Solà, Olga Matas, Júlia Castanys, Ignacio Conget, Marga Giménez
{"title":"Massive switch to an automated insulin delivery system in adults with type 1 diabetes previously treated with sensor-augmented pump due to high risk for hypoglycemia.","authors":"Alex Mesa, Daria Roca, Montse Granados, Irene Pueyo, Carla Cabré, Antonio J Amor, Clara Solà, Olga Matas, Júlia Castanys, Ignacio Conget, Marga Giménez","doi":"10.1016/j.endien.2024.11.004","DOIUrl":"https://doi.org/10.1016/j.endien.2024.11.004","url":null,"abstract":"<p><strong>Introduction: </strong>Automatic insulin delivery (AID) systems improve glycemic control and quality of life in individuals with type 1 diabetes (T1D). Our aim was to assess the feasibility, effectiveness, and safety of switching from a sensor-augmented pump (SAP) to AID in T1D subjects at high risk of hypoglycemia.</p><p><strong>Materials and methods: </strong>A manufacturer-led program consisting of three sessions was implemented. Over three days, all patients completed the first session in-person, in groups of 6-12 people, to receive device training. Subsequently, the automatic mode was activated virtually (session 2), followed by online data download (session 3). Glucometric outcomes were evaluated after one month, along with serious adverse events (SAEs), technical incidents, and perceived satisfaction.</p><p><strong>Results: </strong>The switch was performed in 125 patients, 56.8% of whom were women, with a mean age of 44.1 ± 14.9 years. 99.2% (n = 124) initialized auto-mode. There was an increase in time in range 70-180 mg/dL (64.3 ± 11.3 vs. 74.7 ± 11.2; p < 0.001) and a decrease in time below 70 mg/dL (4.1 ± 3.9 vs. 2.0 ± 1.8; p < 0.001) (N = 97). Forty-one related calls were received, with 10 requiring in-person visits. Medtronic technical service handled 92 related calls (0.74 per patient), from 47 different users (37.6%). One event of severe hypoglycemia was recorded as an SAE. Perceived security and satisfaction with the switch process were high in 91% and 92% of patients, respectively.</p><p><strong>Conclusions: </strong>Massive switch from SAP to AID in T1D patients at high risk of hypoglycemia is feasible and safe through a hybrid program conducted in collaboration with the manufacturer.</p>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142630704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benign familial hyperphosphatasemia: A little-known entity. 良性家族性高磷血症:一个鲜为人知的实体。
IF 1.8 4区 医学
Endocrinologia Diabetes Y Nutricion Pub Date : 2024-11-09 DOI: 10.1016/j.endien.2024.11.005
Antonio Bustos-Merlo, Antonio Rosales-Castillo
{"title":"Benign familial hyperphosphatasemia: A little-known entity.","authors":"Antonio Bustos-Merlo, Antonio Rosales-Castillo","doi":"10.1016/j.endien.2024.11.005","DOIUrl":"https://doi.org/10.1016/j.endien.2024.11.005","url":null,"abstract":"","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142630691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heart failure in people with diabetes and obesity, can it be prevented? 糖尿病和肥胖症患者的心力衰竭可以预防吗?
IF 1.8 4区 医学
Endocrinologia Diabetes Y Nutricion Pub Date : 2024-11-09 DOI: 10.1016/j.endien.2024.10.001
Jesús María de la Hera, Elías Delgado
{"title":"Heart failure in people with diabetes and obesity, can it be prevented?","authors":"Jesús María de la Hera, Elías Delgado","doi":"10.1016/j.endien.2024.10.001","DOIUrl":"https://doi.org/10.1016/j.endien.2024.10.001","url":null,"abstract":"","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2024-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142630695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Papillary thyroid carcinoma on thyroglossal duct cyst: A series of 7 cases 甲状舌管囊肿上的甲状腺乳头状癌:7 例系列病例
IF 1.8 4区 医学
Endocrinologia Diabetes Y Nutricion Pub Date : 2024-10-01 DOI: 10.1016/j.endien.2024.09.004
Belén M. Martínez Mulero, Julia Sastre Marcos, María Ruiz de Ancos, Alejandro Raúl Gratacós Gómez, Lucía Manzano Valero
{"title":"Papillary thyroid carcinoma on thyroglossal duct cyst: A series of 7 cases","authors":"Belén M. Martínez Mulero,&nbsp;Julia Sastre Marcos,&nbsp;María Ruiz de Ancos,&nbsp;Alejandro Raúl Gratacós Gómez,&nbsp;Lucía Manzano Valero","doi":"10.1016/j.endien.2024.09.004","DOIUrl":"10.1016/j.endien.2024.09.004","url":null,"abstract":"","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"71 8","pages":"Pages 365-367"},"PeriodicalIF":1.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142146601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of hypogonadism in men with and without chronic obstructive pulmonary disease: A cross-sectional study 患有和未患有慢性阻塞性肺病的男性性腺功能减退症的患病率:一项横断面研究。
IF 1.8 4区 医学
Endocrinologia Diabetes Y Nutricion Pub Date : 2024-10-01 DOI: 10.1016/j.endien.2024.09.006
Horacio Matías Castro , Pablo Knoblovits , Joaquin Maritano Furcada , Eduardo Luis De Vito , Sebastían Matias Suarez , Pablo Rene Costanzo
{"title":"Prevalence of hypogonadism in men with and without chronic obstructive pulmonary disease: A cross-sectional study","authors":"Horacio Matías Castro ,&nbsp;Pablo Knoblovits ,&nbsp;Joaquin Maritano Furcada ,&nbsp;Eduardo Luis De Vito ,&nbsp;Sebastían Matias Suarez ,&nbsp;Pablo Rene Costanzo","doi":"10.1016/j.endien.2024.09.006","DOIUrl":"10.1016/j.endien.2024.09.006","url":null,"abstract":"<div><h3>Background</h3><div>Hypogonadism is a common finding of chronic obstructive pulmonary disease (COPD). However, the prevalence of hypogonadism in COPD varies among studies. The aim of this study was to determine and compare the prevalence of hypogonadism in men with and without COPD.</div></div><div><h3>Methods</h3><div>We conducted a cross-sectional study with 134 patients with stable COPD and 70 age-matched men with non-COPD. Hypogonadism was defined by the presence of symptoms according to the Androgen Deficiency in Aging Males questionnaire, along with total testosterone deficiency (&lt;300<!--> <!-->ng/dL).</div></div><div><h3>Results</h3><div>Patients had a mean age of 68 years (SD, 6), a body mass index of 28<!--> <!-->kg/m<sup>2</sup> (SD, 6), and 17% were current smokers. The prevalence of hypogonadism was 41.8% in COPD men (<em>N</em> <!-->=<!--> <!-->56, 95%CI, 33–51) and 10.0% in non-COPD men (<em>N</em> <!-->=<!--> <!-->7, 95%CI, 4–20), with a prevalence ratio of 4.2 (95%CI, 2.0–8.7, <em>p</em> <!-->&lt;<!--> <!-->0.001). The prevalence of low total testosterone concentrations (&lt;300<!--> <!-->ng/dL) were significantly higher in COPD patients vs the control group (47.0% vs 15.7%, <em>p</em> <!-->=<!--> <!-->&lt;0.001). In the COPD group, 89.3% of patients had hypogonadotropic hypogonadism and 10.7%, hypergonadotropic hypogonadism. The prevalence of hypogonadism was higher in severe vs non-severe COPD patients (55.8% vs 35.2%; <em>p</em> <!-->=<!--> <!-->0.024).</div></div><div><h3>Conclusions</h3><div>The prevalence of hypogonadism was high and greater in COPD vs non-COPD men. This study suggests that COPD patients should be screened for hypogonadism.</div></div>","PeriodicalId":48650,"journal":{"name":"Endocrinologia Diabetes Y Nutricion","volume":"71 8","pages":"Pages 348-354"},"PeriodicalIF":1.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142394371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信